{
    "code": "52026313",
    "許可證字號": "衛部藥輸字第026313號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "108\/05\/12",
    "發證日期": "103\/05\/12",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202631300",
    "中文品名": "萊特汝膜衣錠2.5毫克",
    "英文品名": "LETERO Film Coating Tablet 2.5mg",
    "適應症": "接受抗動情激素治療失敗的自然或人工停經後之末期乳癌病人之治療。停經後之局部晚期或轉移性乳癌婦女患者之第一線治療用藥。荷爾蒙接受器呈陽性及LN METASTASIS POSITIVE之乳癌病人作為TAMOXIFEN輔助療法之後的延伸治療。停經後荷爾蒙接受器呈陽性反應的初期乳癌病人之輔助治療。",
    "劑型": "116膜衣錠",
    "包裝": "2-1000錠鋁箔盒裝",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "主成分略述": "LETROZOLE",
    "限制項目": [
        "02輸入",
        "24監視期滿學名藥"
    ],
    "申請商名稱": "6201018364  德強企業有限公司",
    "申請商地址": "台北市松山區八德路三段210號10樓",
    "主製造廠": {
        "製造廠名稱": "F200760000  HETERO LABS LIMITED",
        "製造廠廠址": "UNIT-VI, SURVEY NO.410&amp;411, APIIC FORMULATION SEZ, POLEPALLY VILLAGE, JADCHERLA MANDAL,MAHABOOB NAGAR DISTRICT. 509 301, ANDHRA PRADESH, INDIA",
        "製造廠公司地址": "",
        "製造廠國別": "INDIA",
        "製程": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013000400",
            "成分名稱": "LETROZOLE",
            "含量描述": "",
            "含量": "2.5000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "仿單 仿單-103-10-06.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/(S(knoy1cz5iwyfatvvguaez0re))\/ShowFile.aspx?LicId=52026313&Seq=001&Type=9"
        },
        {
            "title": "外盒 標籤-103-10-06.jpg 外盒-103-10-06.jpg 片裝-103-10-06.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/(S(knoy1cz5iwyfatvvguaez0re))\/ShowFile.aspx?LicId=52026313&Seq=003&Type=8"
        }
    ]
}